The process of small molecule drug discovery can be complex and challenging.Small-molecule drugs are听organic compounds affecting molecular pathways by targeting important proteins, which have a low molecular weight, making them penetrate cells easily. Small-molecule drugs can be developed from leads derived from rational drug design or isolated from natural resources.
The global market for Small Molecule Drug Discovery was estimated to be worth US$ 11380 million in 2023 and is forecast to a readjusted size of US$ 15830 million by 2030 with a CAGR of 4.9% during the forecast period 2024-2030
The global small molecule drug discovery market refers to the pharmaceutical industry鈥檚 efforts to discover and develop new drugs based on small organic molecules. Small molecule drugs are chemical compounds with relatively low molecular weight that can interact with specific targets in the body to produce a therapeutic effect.
The market for small molecule drug discovery is driven by the increasing demand for novel and effective drugs to treat various diseases, including cancer, cardiovascular disorders, infectious diseases, and neurological disorders. This market encompasses a wide range of activities, including target identification, hit identification and hit-to-lead optimization, lead optimization, preclinical development, and clinical trials.
Several factors contribute to the growth of this market, such as advancements in drug screening technologies, increased understanding of disease mechanisms, and the availability of genomic and proteomic data. Additionally, the rising prevalence of chronic diseases, population aging, and the need for personalized medicine are also driving the demand for small molecule drug discovery.
The market is highly competitive, with numerous pharmaceutical and biotechnology companies, as well as academic research institutions, involved in drug discovery efforts. These organizations invest significant resources in research and development to identify and develop innovative small molecule drugs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Small Molecule Drug Discovery, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Small Molecule Drug Discovery by region & country, by Type, and by Application.
The Small Molecule Drug Discovery market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Drug Discovery.
麻豆原创 Segmentation
By Company
Johnson and Johnson Services, Inc.
Teva Pharmaceutical Industries Ltd
Boehringer Ingelheim International GmbH
Allergan Plc.
Pfizer Inc.
Bristol-Myers Squibb Company
Merck & Co., Inc
GlaxoSmithKline plc.
AstraZeneca
Gilead Sciences, Inc.
Novartis AG
Johnson & Johnson
Roche Holding AG
AstraZeneca PLC
Sanofi
Segment by Type:
Target Discovery
Target Validation
Lead Generation
Refinement
Preclinical Development
Others
Segment by Application
Oncology
Central Nervous System
Cardiovascular
Respiratory
Orthopedics
Immunology
Rare Diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Small Molecule Drug Discovery manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Small Molecule Drug Discovery in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Small Molecule Drug Discovery in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Small Molecule Drug Discovery Product Introduction
1.2 Global Small Molecule Drug Discovery 麻豆原创 Size Forecast
1.3 Small Molecule Drug Discovery 麻豆原创 Trends & Drivers
1.3.1 Small Molecule Drug Discovery Industry Trends
1.3.2 Small Molecule Drug Discovery 麻豆原创 Drivers & Opportunity
1.3.3 Small Molecule Drug Discovery 麻豆原创 Challenges
1.3.4 Small Molecule Drug Discovery 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Small Molecule Drug Discovery Players Revenue Ranking (2023)
2.2 Global Small Molecule Drug Discovery Revenue by Company (2019-2024)
2.3 Key Companies Small Molecule Drug Discovery Manufacturing Base Distribution and Headquarters
2.4 Key Companies Small Molecule Drug Discovery Product Offered
2.5 Key Companies Time to Begin Mass Production of Small Molecule Drug Discovery
2.6 Small Molecule Drug Discovery 麻豆原创 Competitive Analysis
2.6.1 Small Molecule Drug Discovery 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Small Molecule Drug Discovery Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug Discovery as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Target Discovery
3.1.2 Target Validation
3.1.3 Lead Generation
3.1.4 Refinement
3.1.5 Preclinical Development
3.1.6 Others
3.2 Global Small Molecule Drug Discovery Sales Value by Type
3.2.1 Global Small Molecule Drug Discovery Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Small Molecule Drug Discovery Sales Value, by Type (2019-2030)
3.2.3 Global Small Molecule Drug Discovery Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Oncology
4.1.2 Central Nervous System
4.1.3 Cardiovascular
4.1.4 Respiratory
4.1.5 Orthopedics
4.1.6 Immunology
4.1.7 Rare Diseases
4.1.8 Other
4.2 Global Small Molecule Drug Discovery Sales Value by Application
4.2.1 Global Small Molecule Drug Discovery Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Small Molecule Drug Discovery Sales Value, by Application (2019-2030)
4.2.3 Global Small Molecule Drug Discovery Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Small Molecule Drug Discovery Sales Value by Region
5.1.1 Global Small Molecule Drug Discovery Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Small Molecule Drug Discovery Sales Value by Region (2019-2024)
5.1.3 Global Small Molecule Drug Discovery Sales Value by Region (2025-2030)
5.1.4 Global Small Molecule Drug Discovery Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Small Molecule Drug Discovery Sales Value, 2019-2030
5.2.2 North America Small Molecule Drug Discovery Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Small Molecule Drug Discovery Sales Value, 2019-2030
5.3.2 Europe Small Molecule Drug Discovery Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Small Molecule Drug Discovery Sales Value, 2019-2030
5.4.2 Asia Pacific Small Molecule Drug Discovery Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Small Molecule Drug Discovery Sales Value, 2019-2030
5.5.2 South America Small Molecule Drug Discovery Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Small Molecule Drug Discovery Sales Value, 2019-2030
5.6.2 Middle East & Africa Small Molecule Drug Discovery Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Small Molecule Drug Discovery Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Small Molecule Drug Discovery Sales Value
6.3 United States
6.3.1 United States Small Molecule Drug Discovery Sales Value, 2019-2030
6.3.2 United States Small Molecule Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Small Molecule Drug Discovery Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Small Molecule Drug Discovery Sales Value, 2019-2030
6.4.2 Europe Small Molecule Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Small Molecule Drug Discovery Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Small Molecule Drug Discovery Sales Value, 2019-2030
6.5.2 China Small Molecule Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.5.3 China Small Molecule Drug Discovery Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Small Molecule Drug Discovery Sales Value, 2019-2030
6.6.2 Japan Small Molecule Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Small Molecule Drug Discovery Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Small Molecule Drug Discovery Sales Value, 2019-2030
6.7.2 South Korea Small Molecule Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Small Molecule Drug Discovery Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Small Molecule Drug Discovery Sales Value, 2019-2030
6.8.2 Southeast Asia Small Molecule Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Small Molecule Drug Discovery Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Small Molecule Drug Discovery Sales Value, 2019-2030
6.9.2 India Small Molecule Drug Discovery Sales Value by Type (%), 2023 VS 2030
6.9.3 India Small Molecule Drug Discovery Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Johnson and Johnson Services, Inc.
7.1.1 Johnson and Johnson Services, Inc. Profile
7.1.2 Johnson and Johnson Services, Inc. Main Business
7.1.3 Johnson and Johnson Services, Inc. Small Molecule Drug Discovery Products, Services and Solutions
7.1.4 Johnson and Johnson Services, Inc. Small Molecule Drug Discovery Revenue (US$ Million) & (2019-2024)
7.1.5 Johnson and Johnson Services, Inc. Recent Developments
7.2 Teva Pharmaceutical Industries Ltd
7.2.1 Teva Pharmaceutical Industries Ltd Profile
7.2.2 Teva Pharmaceutical Industries Ltd Main Business
7.2.3 Teva Pharmaceutical Industries Ltd Small Molecule Drug Discovery Products, Services and Solutions
7.2.4 Teva Pharmaceutical Industries Ltd Small Molecule Drug Discovery Revenue (US$ Million) & (2019-2024)
7.2.5 Teva Pharmaceutical Industries Ltd Recent Developments
7.3 Boehringer Ingelheim International GmbH
7.3.1 Boehringer Ingelheim International GmbH Profile
7.3.2 Boehringer Ingelheim International GmbH Main Business
7.3.3 Boehringer Ingelheim International GmbH Small Molecule Drug Discovery Products, Services and Solutions
7.3.4 Boehringer Ingelheim International GmbH Small Molecule Drug Discovery Revenue (US$ Million) & (2019-2024)
7.3.5 Allergan Plc. Recent Developments
7.4 Allergan Plc.
7.4.1 Allergan Plc. Profile
7.4.2 Allergan Plc. Main Business
7.4.3 Allergan Plc. Small Molecule Drug Discovery Products, Services and Solutions
7.4.4 Allergan Plc. Small Molecule Drug Discovery Revenue (US$ Million) & (2019-2024)
7.4.5 Allergan Plc. Recent Developments
7.5 Pfizer Inc.
7.5.1 Pfizer Inc. Profile
7.5.2 Pfizer Inc. Main Business
7.5.3 Pfizer Inc. Small Molecule Drug Discovery Products, Services and Solutions
7.5.4 Pfizer Inc. Small Molecule Drug Discovery Revenue (US$ Million) & (2019-2024)
7.5.5 Pfizer Inc. Recent Developments
7.6 Bristol-Myers Squibb Company
7.6.1 Bristol-Myers Squibb Company Profile
7.6.2 Bristol-Myers Squibb Company Main Business
7.6.3 Bristol-Myers Squibb Company Small Molecule Drug Discovery Products, Services and Solutions
7.6.4 Bristol-Myers Squibb Company Small Molecule Drug Discovery Revenue (US$ Million) & (2019-2024)
7.6.5 Bristol-Myers Squibb Company Recent Developments
7.7 Merck & Co., Inc
7.7.1 Merck & Co., Inc Profile
7.7.2 Merck & Co., Inc Main Business
7.7.3 Merck & Co., Inc Small Molecule Drug Discovery Products, Services and Solutions
7.7.4 Merck & Co., Inc Small Molecule Drug Discovery Revenue (US$ Million) & (2019-2024)
7.7.5 Merck & Co., Inc Recent Developments
7.8 GlaxoSmithKline plc.
7.8.1 GlaxoSmithKline plc. Profile
7.8.2 GlaxoSmithKline plc. Main Business
7.8.3 GlaxoSmithKline plc. Small Molecule Drug Discovery Products, Services and Solutions
7.8.4 GlaxoSmithKline plc. Small Molecule Drug Discovery Revenue (US$ Million) & (2019-2024)
7.8.5 GlaxoSmithKline plc. Recent Developments
7.9 AstraZeneca
7.9.1 AstraZeneca Profile
7.9.2 AstraZeneca Main Business
7.9.3 AstraZeneca Small Molecule Drug Discovery Products, Services and Solutions
7.9.4 AstraZeneca Small Molecule Drug Discovery Revenue (US$ Million) & (2019-2024)
7.9.5 AstraZeneca Recent Developments
7.10 Gilead Sciences, Inc.
7.10.1 Gilead Sciences, Inc. Profile
7.10.2 Gilead Sciences, Inc. Main Business
7.10.3 Gilead Sciences, Inc. Small Molecule Drug Discovery Products, Services and Solutions
7.10.4 Gilead Sciences, Inc. Small Molecule Drug Discovery Revenue (US$ Million) & (2019-2024)
7.10.5 Gilead Sciences, Inc. Recent Developments
7.11 Novartis AG
7.11.1 Novartis AG Profile
7.11.2 Novartis AG Main Business
7.11.3 Novartis AG Small Molecule Drug Discovery Products, Services and Solutions
7.11.4 Novartis AG Small Molecule Drug Discovery Revenue (US$ Million) & (2019-2024)
7.11.5 Novartis AG Recent Developments
7.12 Johnson & Johnson
7.12.1 Johnson & Johnson Profile
7.12.2 Johnson & Johnson Main Business
7.12.3 Johnson & Johnson Small Molecule Drug Discovery Products, Services and Solutions
7.12.4 Johnson & Johnson Small Molecule Drug Discovery Revenue (US$ Million) & (2019-2024)
7.12.5 Johnson & Johnson Recent Developments
7.13 Roche Holding AG
7.13.1 Roche Holding AG Profile
7.13.2 Roche Holding AG Main Business
7.13.3 Roche Holding AG Small Molecule Drug Discovery Products, Services and Solutions
7.13.4 Roche Holding AG Small Molecule Drug Discovery Revenue (US$ Million) & (2019-2024)
7.13.5 Roche Holding AG Recent Developments
7.14 AstraZeneca PLC
7.14.1 AstraZeneca PLC Profile
7.14.2 AstraZeneca PLC Main Business
7.14.3 AstraZeneca PLC Small Molecule Drug Discovery Products, Services and Solutions
7.14.4 AstraZeneca PLC Small Molecule Drug Discovery Revenue (US$ Million) & (2019-2024)
7.14.5 AstraZeneca PLC Recent Developments
7.15 Sanofi
7.15.1 Sanofi Profile
7.15.2 Sanofi Main Business
7.15.3 Sanofi Small Molecule Drug Discovery Products, Services and Solutions
7.15.4 Sanofi Small Molecule Drug Discovery Revenue (US$ Million) & (2019-2024)
7.15.5 Sanofi Recent Developments
8 Industry Chain Analysis
8.1 Small Molecule Drug Discovery Industrial Chain
8.2 Small Molecule Drug Discovery Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Small Molecule Drug Discovery Sales Model
8.5.2 Sales Channel
8.5.3 Small Molecule Drug Discovery Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Johnson and Johnson Services, Inc.
Teva Pharmaceutical Industries Ltd
Boehringer Ingelheim International GmbH
Allergan Plc.
Pfizer Inc.
Bristol-Myers Squibb Company
Merck & Co., Inc
GlaxoSmithKline plc.
AstraZeneca
Gilead Sciences, Inc.
Novartis AG
Johnson & Johnson
Roche Holding AG
AstraZeneca PLC
Sanofi
听
听
*If Applicable.
